However, despite selecting an effective IFN-γ antibody for staining, we noted suboptimal immunohistochemical staining of IFN-γ, resulting in an undetectable level of GZMA+IFN-γ+CD8+TILs in many colon cancer samples. The gene discussed is IFNG; the disease is malignant colon neoplasm.